Navigation Links
MiMedx Announces Brian J. Splan as President
Date:3/3/2008

TAMPA, Fla., March 3 /PRNewswire/ -- MiMedx, Inc., a development-stage medical device company, announced today that Brian J. Splan has been appointed President. In this role, Mr. Splan will be providing strategic and tactical leadership to the MiMedx team.

Throughout his 34-year career, Mr. Splan has consistently demonstrated the ability to manage a wide range of operations and deliver excellent results for customers and shareholders. Beginning in 1986, Mr. Splan was employed by Smith & Nephew, Inc. in a variety of positions of increasing responsibility. Mr. Splan was Executive Vice President of Finance and Administration of Smith & Nephew, Inc., President of Ioptex Research, Inc., a subsidiary of Smith & Nephew, PLC. He also served as President of the Healthcare Division of Smith & Nephew, Inc. US operations.

"We are delighted to have the opportunity to add someone of Brian's caliber to our senior management team," said Tom D'Alonzo, CEO of MiMedx. "His extensive experience will help us to accelerate our exciting discoveries into product candidates."

MiMedx recently became a public Company through a reverse merger with Alynx, Co. For more information on MiMedx, see http://www.mimedx.com.

About MiMedx, Inc.

Founded in 2006, MiMedx, Inc. is a development-stage Florida corporation with technology focusing on biomaterials for soft tissue repair, such as tendons, ligaments and cartilage, as well as other biomaterial-based products for other medical applications. The company, based in Tampa, Florida, holds an exclusive, worldwide license from the Shriner's Hospital for Children and the University of South Florida Research Foundation for certain nordihydroguaiaretic acid (NDGA) technology. MiMedx is targeting this proprietary technology for a number of diverse medical applications.

MiMedx, Inc. also has a wholly-owned subsidiary, SpineMedica, LLC, based in Atlanta, Georgia,
'/>"/>

SOURCE MiMedx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
2. Boston Scientific Announces European Approval of New Heart Failure Lead
3. WaferGen Announces Management Team Promotions
4. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
5. BioWa Announces Expansion of License Agreement with Genentech for BioWas POTELLIGENT(R) Technology
6. DW Healthcare Partners Announces the Sale of Tandem Labs
7. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
8. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
9. MarketResearch.com Announces Distribution of Spectra Intelligence Research
10. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
11. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Savoury Systems International (SSI), a leader in the ... USA Sales Broker. Braddy’s new role will allow SSI ... , In 2004 Braddy founded Southeastern Food ... processors and industrial manufacturers. Braddy has worked for ... has over 25 years of sales management experience. ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... Md. , May 21, 2013  Synthetic Biologics, Inc. ... prevention and treatment of serious infectious diseases, announced today that ... the 2 nd Annual Marcum LLP MicroCap Conference on ... at the Grand Hyatt Hotel. Mr. Riley is ... A live webcast of Synthetic Biologics, presentation can be accessed ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 NANONEX ... nanoimprint solutions , today announced the successful delivery ... manufacturing system, the NX-M200B, to a major Japanese ... is a fully-automated, production-ready, advanced nanoimprint lithography tool ... of wafer and substrate sizes and types. Based ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the ... for the period ended March 31, 2011. The Company reported ... loss from operations of $(15.0) million in the 2010 first ... $(0.00) per share, compared to a loss in the same ...
... BALTIMORE and LIEGE, Belgium, May 9, 2011 BD ... (Becton, Dickinson and Company) (NYSE: BDX ), ... Belgium, announced today an agreement to co-develop seven initial ... pathogens associated with respiratory, enteric and central nervous system ...
... May 9, 2011 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... and operational highlights for the quarter ended March 31, 2011. ... of $58.4 million compared to net revenues of $45.5 million ... the first quarter of 2011 was $(11.8) million, or $(0.25) ...
Cached Biology Technology:Advanced Cell Technology Announces 2011 First Quarter Results 2Advanced Cell Technology Announces 2011 First Quarter Results 3BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 2BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 3BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 4Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 2Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 3Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 4Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 5Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 6Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 7Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights 8
(Date:5/21/2013)... world,s largest scientific society, invites news media coverage ... 8-12, 2013, in Indianapolis, Ind. It will take ... area hotels. , With more than 7,100 presentations ... from astronomy to zoology ― the meeting will ... assortment of spot news and feature possibilities. The ...
(Date:5/21/2013)... way genes function without changing the underlying DNA ... of pregnant women during any trimester, potentially providing ... weeks after giving birth, and an opportunity to ... of the small study involving 52 pregnant women ... Psychiatry . , "Postpartum depression can be harmful ...
(Date:5/20/2013)... New research suggests that a compound abundant in ... escape death. , By altering a very specific ... cells into normal cells that die as scheduled. , ... a process that would cause them to die on ... This study in cells, led by Ohio State University ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... Scientists are to study a group of proteins that are ... key to developing new types of antibiotics. Researchers from ... from the Biotechnology and Biological Sciences Research Council (BBSRC) to ... force their way into bacterial cells before destroying them. ...
... London, 1 July, 2009 Johnson & Johnson ... Department of Molecular Biology at the Max Planck Institute ... novel cancer therapies including Herceptin (trastuzumab) , is the ... Biomedical Research. An independent committee of world-renowned scientists ...
... DNA strands damaged by oxidation leads to several types ... to the development of cancer. That,s the conclusion of ... researchers at the National Institute of Standards and Technology ... New York University School of Medicine (NYUSM). Although ...
Cached Biology News:Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Genetically engineered mice yield clues to 'knocking out' cancer 2
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
... is an ideal small concentrator for the ... of removing water and organic solvents from ... microplates, vials and round bottom flasks. Making ... busy lab. ,The built-in special runs for ...
... a compact, versatile & modular instrument which can ... Intracellular, Extracellular, Transducer & Multi-channel Isolated Amplification ... & Power Supply unit (NL900D) forms the heart ... only powered by this unit, but wiring within ...
... Precision Model 410 is a four-channel general purpose ... small signals from sources which may have a ... channel consists of a high gain/low noise amplifier, ... and an output offset control. A control knob ...
Biology Products: